Skip to Content

OrganiGram Holdings Inc OGI

Morningstar Rating
CAD 2.64 −0.28 (9.59%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OGI is trading at a 39% discount.
Price
CAD 2.66
Fair Value
CAD 4.98
Uncertainty
Extreme
1-Star Price
CAD 64.52
5-Star Price
CAD 1.82
Economic Moat
Pvh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OGI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 2.92
Day Range
CAD 2.602.89
52-Week Range
CAD 1.353.95
Bid/Ask
CAD 2.63 / CAD 2.67
Market Cap
CAD 271.92 Mil
Volume/Avg
806,762 / 479,450

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.32
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o’ Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram’s existing brand portfolio.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
935

Comparables

Valuation

Metric
OGI
CURA
CRON
Price/Earnings (Normalized)
Price/Book Value
0.834.090.98
Price/Sales
1.323.0912.13
Price/Cash Flow
72.87
Price/Earnings
OGI
CURA
CRON

Financial Strength

Metric
OGI
CURA
CRON
Quick Ratio
1.880.3121.68
Current Ratio
4.280.8522.54
Interest Coverage
−0.24
Quick Ratio
OGI
CURA
CRON

Profitability

Metric
OGI
CURA
CRON
Return on Assets (Normalized)
−3.72%−0.53%
Return on Equity (Normalized)
−10.45%−0.55%
Return on Invested Capital (Normalized)
−2.20%−4.90%
Return on Assets
OGI
CURA
CRON
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AKxrlkmlbllFbsn$72.4 Bil
MKKGY
Merck KGaA ADRCsyshfwmKtnyyzd$69.1 Bil
HLN
Haleon PLC ADRWjdkkdhfkGbfzv$37.8 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRMyxtnyhxKzzk$15.7 Bil
VTRS
Viatris IncSvflsnyvTxgbp$13.8 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWnpnpfrDsxb$12.4 Bil
CTLT
Catalent IncTvtgnlrfnTndwwq$10.1 Bil
PRGO
Perrigo Co PLCRmpgjvwcNdqg$4.5 Bil
CURLF
Curaleaf Holdings IncBqmrksmczMpr$4.1 Bil
PBH
Prestige Consumer Healthcare IncSmfwthrCnnlzq$3.5 Bil

Sponsor Center